Traditional Therapy Clinics Ltd (ASX:TTC) has successfully generated strong business and EBIT growth of more than 10% for its Chinese RMB operations since its IPO in 2015. This growth has been primarily generated by a careful expansion of both its franchised clinics and company owned clinics.

The 2017 East Coles / Transplant Australia Corporate Performance Awards will be held at the Ivy Ballroom in September.

Treatment for sleep apnoea usually involves either a mask or a mouthguard. A new Australian invention combines the best elements of both. Brisbane dentist Chris Hart spent years struggling to sleep. He snored constantly. He often woke up during the night because he had stopped breathing because of a n obstruction in his nose and throat.

Oventus Medical Ltd (ASX:OVN) is pleased to provide the Company's latest Investor Presentation.

Respiratory technology company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to announce that it has been advised by Sigma Healthcare (ASX:SIG) that Mute sleep technology will form part of the 2017 core range for the Amcal and Guardian pharmacy brands.

Australian medical device company Oventus Medical Ltd. (ASX:OVN), has lodged an FDA 510k submission for its O2Vent W device - an oral appliance intended to reduce or alleviate snoring, mild to moderate obstructive sleep apnoea and severe sleep apnoea when the patient is intolerant to Continuous Positive Airway Pressure Devices.

Sleep disorder device manufacturer and developer Oventus Medical Ltd. (ASX:OVN) is pleased to announce significant progress has been made regarding the clinical validation of the Oventus O2Vent oral appliances and, in particular, validation of the benefit of the Oventus proprietary airway.

Sleep disorder device manufacturer and developer Oventus Medical Ltd. (ASX:OVN) is pleased to announce significant clinical progress made with the Oventus O2Vent oral appliance with a Positive Airway connection.

Traditional Therapy Clinics Limited (ASX:TTC) advises investors that business continues as usual, and the Company is continuing to pursue its stated strategy to own more owner operated clinics, as well as diversify its service offering into the aged care sector, supplement by providing education for the healthcare industry.

Oventus Medical Ltd (ASX:OVN) will unveil latest advancements in the field, which are changing the way the disease is treated, in San Francisco next week (April 20th). Dr Chris Hart will join more than 30 international speakers at 3DHEALS2017 - the first collaborative conference in the U.S. aiming to create a global healthcare community focusing on 3D printing and related technologies.